Qube Research & Technologies (QRT)
IRON icon

Qube Research & Technologies (QRT)’s Disc Medicine IRON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-74,777
Closed -$4.66M – 4268
2024
Q1 		$4.66M Buy
74,777
+24,066
+47% +$1.56M 0.01% 1275
2023
Q4 		$2.93M Buy
+50,711
New +$2.6M 0.01% 1334
2022
Q4 		– Sell
-549
Closed -$27K – 2732
2022
Q3 		$27K Sell
549
-71
-11% -$3.35K ﹤0.01% 2254
2022
Q2 		$31K Buy
+620
New +$27.4K ﹤0.01% 2204

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IRON Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 74,777 shares — an estimated $4.66M sold.

Qube Research & Technologies (QRT) first reported a position in IRON in Q2 2022 and held it in 4 quarters. The position peaked at $4.66M in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 74,777 Disc Medicine shares in Q2 2024, an estimated $4.66M.
  • Qube Research & Technologies (QRT) first reported a position in Disc Medicine in Q2 2022 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Disc Medicine position peaked at $4.66M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.